Kimberly-Clark to Sell Assets Over $40 Billion Kenvue Deal EU Antitrust Concerns

M&A · PartnershipRegulation
โดย Simply Wall St·EUUS·Read original
Summary · why it matters

Kimberly-Clark plans to sell assets tied to its planned US$40b acquisition of consumer products group Kenvue in order to address European Union antitrust concerns. The disposals target overlaps in consumer health and personal care brands, with asset sale discussions focused on EU markets where regulators flagged competition issues during their ongoing review of the Kenvue deal. Kimberly-Clark, a US household products group with a market cap of about US$32.6b, earns its money from personal care brands that sit close to Kenvue's consumer health and hygiene lines, which is exactly where regulators are probing for competitive overlap in Europe. The planned Kenvue acquisition, together with the targeted EU disposals, pushes Kimberly-Clark closer to Procter & Gamble and Colgate-Palmolive in terms of breadth, while the asset sales suggest management is prepared to trim overlap to keep the deal on track. Selling brands to satisfy regulators may reduce competitive pressure, but it also shrinks the pool of potential synergies and places more weight on flawless integration and disciplined marketing to maintain pricing power.

Impact on stocks 4

Consumer Staples▲ · 4 stocks
Kimberly-Clark Corporation
KMB
± MixedRegulationrelevance

Kimberly-Clark plans EU asset sales to address antitrust concerns over its $40B Kenvue acquisition, trimming overlap but reducing synergies.

Kenvue Inc.
KVUE
± MixedRegulationrelevance

Kenvue is the acquisition target whose deal faces EU antitrust review, prompting Kimberly-Clark's planned asset disposals.

© 2026 MarketDXNews